India’s Pharmaceutical company Hetero received WHO’s backing for its generic version of Covid-19 oral antiviral treatment candidate ‘Nirmatrelvir’ India’s Pharmaceutical company Hetero said it has received World Health Organization (WHO) Prequalification of medicines program (WHO PQ) approval for its generic version of Covid-19 oral antiviral treatment candidate ‘Nirmatrelvir’. It said that it is the first … Continue reading Alert! Covid treatments have now been available in the form of pills, which is a deceptive approach by the WHO.